Search - tctmd.com

Displaying 421 - 440 of 662

Sort: Relevancy | Date

Presentation TCT 2018

TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation

Presenter: Anibal A. Damonte

September 21, 2018

Presentation TCT 2018

Mitra Clip in the Spotlight: What Should We Proceed After the MITRA-FR Trial?

Presenter: Marco Alcantara

September 21, 2018

Presentation TCT 2018

Mitral Valvular Heart Disease: Diagnosis and Treatment Options 2018

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Ramon Quesada

September 21, 2018

Presentation TCT 2018

Aortic Valvular Heart Disease: Diagnosis and Treatment Options 2018

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Nicola Corvaja

September 21, 2018

Presentation TCT 2018

How to Select Patients for Tricuspid Valve Repair

Presenter: Jeroen J. Bax, Stephan Windecker, Jörg Hausleiter

September 21, 2018

Presentation TCT 2018

The Future of Transcatheter Mitral Valve Intervention: Repair or Replace?

Presenter: Jeroen J. Bax, Stephan Windecker, Georg Nickenig

September 21, 2018

Presentation TCT 2018

Antithrombotic Therapy in Patients Undergoing TAVR

Presenter: Jeroen J. Bax, Stephan Windecker

September 21, 2018

Presentation TCT 2018

TAVR: New Indications and Unmet Needs

Presenter: Jeroen J. Bax, Stephan Windecker, Thomas Pilgrim

September 21, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News TCT 2017

Early Pilot Study Results Show Symptom Improvement With TMVR

Michael O'Riordan

November 07, 2017

News Conference News TCT 2017

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

Ashley Lyles

November 06, 2017

News Conference News TCT 2017

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Yael L. Maxwell

November 02, 2017

Presentation TCT 2017

Adjunctive Pharmacotherapy During and After TAVR: Current Trends, New Studies, and the Case for Short-term (3-6 months) Systemic Anticoagulation

Presenter: Eberhard Grube, James B. Hermiller Jr., Pascal Vranckx

November 01, 2017

Presentation TCT 2017

A Primer of Conduction Abnormalities after TAVR: Frequency, Clinical Consequences, and Revised Management Recommendations (New Permanent Pacemakers)

Presenter: Eberhard Grube, James B. Hermiller Jr., Hemal Gada

November 01, 2017

Presentation TCT 2017

Hemodynamic Trends on Serial Echocardiograms after TAVR: Comprehensive 5-Year Analyses From PARTNER

Presenter: Pamela S. Douglas

November 01, 2017

Presentation TCT 2017

Valve Durability after TAVR: Definitions, Surgical Valve Predicates, and Review of Available Data

Presenter: Danny Dvir

November 01, 2017

Presentation TCT 2017

The Clinical Relevance of Valve Leaflet Thickening after TAVR

Presenter: Raj Makkar

November 01, 2017

Presentation TCT 2017

Underutilization of TAVR in Minority Populations: Scope, Etiologies, and Possible Solutions

Presenter: Eberhard Grube, James B. Hermiller Jr., Oluseun Alli

November 01, 2017

Presentation TCT 2017

Shared Decision-making is an Essential Component of the Modern-era Heart Team: Rationale and Integration with TAVR Clinical Practice

Presenter: Eberhard Grube, James B. Hermiller Jr., Megan Coylewright

November 01, 2017

Presentation TCT 2017

Counterpoint More than Two TAVR Devices on Your Shelf is Unnecessary!

Presenter: Haim Danenberg

November 01, 2017

Advertisement

TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation

Mitra Clip in the Spotlight: What Should We Proceed After the MITRA-FR Trial?

Mitral Valvular Heart Disease: Diagnosis and Treatment Options 2018

Aortic Valvular Heart Disease: Diagnosis and Treatment Options 2018

How to Select Patients for Tricuspid Valve Repair

The Future of Transcatheter Mitral Valve Intervention: Repair or Replace?

Antithrombotic Therapy in Patients Undergoing TAVR

TAVR: New Indications and Unmet Needs

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Early Pilot Study Results Show Symptom Improvement With TMVR

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Adjunctive Pharmacotherapy During and After TAVR: Current Trends, New Studies, and the Case for Short-term (3-6 months) Systemic Anticoagulation

A Primer of Conduction Abnormalities after TAVR: Frequency, Clinical Consequences, and Revised Management Recommendations (New Permanent Pacemakers)

Hemodynamic Trends on Serial Echocardiograms after TAVR: Comprehensive 5-Year Analyses From PARTNER

Valve Durability after TAVR: Definitions, Surgical Valve Predicates, and Review of Available Data

The Clinical Relevance of Valve Leaflet Thickening after TAVR

Underutilization of TAVR in Minority Populations: Scope, Etiologies, and Possible Solutions

Shared Decision-making is an Essential Component of the Modern-era Heart Team: Rationale and Integration with TAVR Clinical Practice

Counterpoint More than Two TAVR Devices on Your Shelf is Unnecessary!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content